Products
Latest News
FAQ
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
Adenomyosis and ART
Phase 4
Recruiting
Conditions
Adenomyosis
Interventions
Drug: Dienogest 2 MG (milligram)
Drug: long GnRH agonist or flexible GnRH antagonist protocol.
Drug: Enantone
Subscribe
First Posted Date
2023-07-10
Last Posted Date
2023-07-10
Lead Sponsor
Azienda Ospedaliero-Universitaria di Modena
Target Recruit Count
500
Registration Number
NCT05937490
Locations
🇮🇹
Azienda Ospedaliero-Universitaria di Modena, Modena, Italy
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy